ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 2 filers reported holding ARRAY BIOPHARMA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $25,140,000 | +1167.1% | 542,638 | +566.7% | 0.03% | +933.3% |
| Q1 2019 | $1,984,000 | +737.1% | 81,394 | +390.3% | 0.00% | – |
| Q4 2018 | $237,000 | -57.5% | 16,600 | -54.7% | 0.00% | -100.0% |
| Q3 2018 | $557,000 | +140.1% | 36,643 | +157.7% | 0.00% | – |
| Q1 2018 | $232,000 | -92.3% | 14,218 | -94.0% | 0.00% | -100.0% |
| Q4 2017 | $3,026,000 | +49.1% | 236,436 | +43.4% | 0.00% | +33.3% |
| Q3 2017 | $2,029,000 | +1391.9% | 164,933 | +984.4% | 0.00% | – |
| Q1 2017 | $136,000 | -2.9% | 15,209 | -26.5% | 0.00% | – |
| Q3 2016 | $140,000 | +204.3% | 20,681 | +34.0% | 0.00% | – |
| Q1 2016 | $46,000 | -62.0% | 15,428 | -46.4% | 0.00% | – |
| Q4 2015 | $121,000 | -2.4% | 28,762 | +5.9% | 0.00% | – |
| Q3 2015 | $124,000 | -59.7% | 27,159 | -34.9% | 0.00% | – |
| Q1 2015 | $308,000 | -81.7% | 41,750 | -88.2% | 0.00% | -100.0% |
| Q4 2014 | $1,679,000 | +783.7% | 355,069 | +836.0% | 0.00% | – |
| Q4 2013 | $190,000 | -55.4% | 37,935 | -44.6% | 0.00% | -100.0% |
| Q3 2013 | $426,000 | -82.5% | 68,466 | -87.2% | 0.00% | -80.0% |
| Q2 2013 | $2,430,000 | – | 535,083 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Advisory Services Network, LLC | 3,442 | $159,000 | 0.01% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |